About: Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $13.88 (+6.28%)
CBIO NASDAQ Crescent Biopharma, Inc.
Crescent Biopharma, Inc. share price
Atividade de preço de CBIO
Último preço
$ 13,880
Variação (24h)
0,82 USD (6,28%)
Volume
128.30K
Volume (média 4 sem.)
-
Abertura
$ 13,43
Variação do dia
$ 13,17 - $ 14,01
Fechamento anterior
$ 13,06
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
CBIO price performance
Atrasado
04 Nov, 9:00 pm GMT+0
CBIO details
quote.marketSignals